Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Guilhot

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
The Oncologist|June 1, 2004
Indications for imatinib mesylate therapy and clinical managementFrançois Guilhot
Blood|November 1, 2024
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemiaFrançois Guilhot, Rüdiger Hehlmann
Nature Reviews. Clinical Oncology|November 28, 2009
Hematology: dasatinib regimens for patients with chronic myeloid leukemiaFrançois Guilhot, Lydia Roy
Current Opinion in Hematology|January 10, 2012
Current treatment strategies in chronic myeloid leukemiaFrançois Guilhot, Lydia Roy, Cécile Tomowiak
Hematology/Oncology Clinics of North America|July 24, 2004
Interferon therapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Joëlle Guilhot, et al.
Cancer|October 28, 2014
Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rulesJoëlle Guilhot, Claude Preudhomme, Francois Xavier Mahon, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
Interferon in chronic myeloid leukaemia: past and futureFrançois Guilhot, Lydia Roy, Pierre-Jean Saulnier, et al.
Hematological Oncology|April 22, 2017
Age-related health care disparities in multiple myelomaMathieu Puyade, Gautier Defossez, François Guilhot, et al.
Leukemia Research|April 28, 2004
Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CMLFrançoise Brizard, Marie Cividin, Claire Villalva, et al.
Clinical Lymphoma & Myeloma|March 27, 2007
Immunotherapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Geraldine Martineua, et al.
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
The Oncologist|June 1, 2004
Indications for imatinib mesylate therapy and clinical managementFrançois Guilhot
Blood|November 1, 2024
Long-term outcomes of tyrosine kinase inhibitors in chronic myeloid leukemiaFrançois Guilhot, Rüdiger Hehlmann
Nature Reviews. Clinical Oncology|November 28, 2009
Hematology: dasatinib regimens for patients with chronic myeloid leukemiaFrançois Guilhot, Lydia Roy
Current Opinion in Hematology|January 10, 2012
Current treatment strategies in chronic myeloid leukemiaFrançois Guilhot, Lydia Roy, Cécile Tomowiak
Hematology/Oncology Clinics of North America|July 24, 2004
Interferon therapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Joëlle Guilhot, et al.
Cancer|October 28, 2014
Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rulesJoëlle Guilhot, Claude Preudhomme, Francois Xavier Mahon, et al.
Best Practice & Research. Clinical Haematology|December 5, 2009
Interferon in chronic myeloid leukaemia: past and futureFrançois Guilhot, Lydia Roy, Pierre-Jean Saulnier, et al.
Hematological Oncology|April 22, 2017
Age-related health care disparities in multiple myelomaMathieu Puyade, Gautier Defossez, François Guilhot, et al.
Leukemia Research|April 28, 2004
Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CMLFrançoise Brizard, Marie Cividin, Claire Villalva, et al.
Clinical Lymphoma & Myeloma|March 27, 2007
Immunotherapy in chronic myelogenous leukemiaFrançois Guilhot, Lydia Roy, Geraldine Martineua, et al.
Pageof 11